InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Dalal Anupam, Director. Officer active across 2 companies, notably Aerpio Pharmaceuticals, Inc.. Aggregated, 6 reports have been published. Total volume traded: €68m. The latest transaction was disclosed on 26 August 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€17m1,529,402 shares@ €11.123350.0% of flow
Common Stock
SEC:0000899243-21-034635·
Ideal exit: 23 May 2022 (T+270)
€17m1,529,402 shares@ €11.123325.0% of flow
Common Stock
SEC:0000899243-21-034635:0·
Ideal exit: 23 May 2022 (T+270)
€17m1,529,402 shares@ €11.123350.0% of flow
Common Stock
SEC:0000899243-21-034546·
Ideal exit: 23 May 2022 (T+270)
€17m1,529,402 shares@ €11.123325.0% of flow
Common Stock
SEC:0000899243-21-034546:0·
Ideal exit: 23 May 2022 (T+270)
€9,4877,400 shares@ €1.282100.0% of flow
Common Stock
SEC:0000899243-21-027291·
€9,4877,400 shares@ €1.28250.0% of flow
Common Stock
SEC:0000899243-21-027291:0·
6 of 6 declarations
About Dalal Anupam
Anupam Dalal is a Board Member at Aerpio Pharmaceuticals, Inc. and Aadi Bioscience, Inc. He contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. His expertise is valuable for the development of these organizations.
